Skip to main content

Table 3 Impact of adalimumab dose and screening on tuberculosis rates

From: Does safety make a difference in selecting the right TNF antagonist?

Trial phase

Intensity of dosea

Screening by chest X-ray

Patients tested

Tuberculosis cases

I

×20

No

198

5

II

×4

No

284

3

III

×2

Yes

511

0

  1. aNumber of times above the commonly administered dose of 40 mg every 2 weeks. Data on file, Abbott Laboratories, Abbott Park, IL, USA.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us